Insider track record
OtherAcross 7 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Discover the full record of transactions filed by Morrison Briggs. Insider active across 4 companies, notably Syndax Pharmaceuticals Inc. In total, 24 reports have been published. Breakdown: 0 buy · 1 sell. Total volume traded: €94k. History available since 17 September 2021. The latest transaction was disclosed on 29 May 2024 (Attribution). Regulator: SEC (Form 4). The full history is free.
Declarations24 total
15,527 sharesCommon StockSEC:0001628280-26-045786:0
5,899 shares0Common StockSEC:0001655759-24-000083:0
17,000 shares0Common StockSEC:0001562180-24-001216:0
52,855 shares@ US$8.779.3% of flowCommon StockSEC:0001562180-23-006262:0
52,855 shares@ US$8.779.3% of flowCommon StockSEC:0001562180-23-005845:0
4,121 shares0Common StockSEC:0001655759-23-000065:0
24,582 shares@ US$6.383.2% of flowCommon StockSEC:0001562180-23-005057:0
52,855 shares@ US$6.386.8% of flowCommon StockSEC:0001562180-23-004032:0
52,855 shares@ US$6.386.8% of flowCommon StockSEC:0001562180-23-003521:0
52,854 shares@ US$6.387.0% of flowCommon StockSEC:0001562180-23-002770:0
12,175 sharesCommon StockSEC:0001104659-23-030746:0
52,854 shares@ US$6.386.9% of flowCommon StockSEC:0001562180-23-001117:0
114,339 shares@ US$10.9027.4% of flowCommon StockSEC:0001562180-22-006788:0
87,645 shares@ US$7.2013.9% of flowCommon StockSEC:0001562180-22-006706:0
62,292 shares@ US$7.209.4% of flowCommon StockSEC:0001562180-22-005475:0
16,188 shares@ US$16.000.031% mcap34.6% of flowCommon StockSEC:0001209191-22-024674:0
70,545 shares@ US$7.200.026% mcap22.0% of flowCommon StockSEC:0001562180-22-003383:0
6,000 shares@ US$17.43890.0053% mcap4.5% of flowCommon StockSEC:0001562180-22-003223:0
16,188 shares@ US$16.000.030% mcap32.7% of flowCommon StockSEC:0000899243-22-002557:0
16,188 shares@ US$16.0032.7% of flowCommon StockSEC:0000899243-22-002557
35,156 shares@ US$10.9016.2% of flowCommon StockSEC:0001562180-21-007810
35,156 shares@ US$10.900.019% mcap16.2% of flowCommon StockSEC:0001562180-21-007810:0
70,262 shares@ US$7.200.024% mcap20.6% of flowCommon StockSEC:0001562180-21-006038:0
70,262 shares@ US$7.2020.6% of flowCommon StockSEC:0001562180-21-006038
About Morrison Briggs
Morrison Briggs is a director at Syndax Pharmaceuticals Inc and an insider at multiple companies, including Arvinas, INC.